| scholarly article | Q13442814 |
| P50 | author | Zhi-Chuan Zhu | Q88007971 |
| P2093 | author name string | Can Yang | |
| Zhi-Qi Xiong | |||
| Ming-Jie Li | |||
| Ji-Wei Liu | |||
| Rong-Jie Wu | |||
| P2860 | cites work | TRAF2 Sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer. | Q50549602 |
| KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells. | Q55081473 | ||
| Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin. | Q55467802 | ||
| Inhibition of vacuolar ATPase attenuates the TRAIL-induced activation of caspase-8 and modulates the trafficking of TRAIL receptosomes | Q24292952 | ||
| Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor | Q24297204 | ||
| Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling | Q24308725 | ||
| Getting TRAIL back on track for cancer therapy | Q27027460 | ||
| ER stress-induced cell death mechanisms | Q27027638 | ||
| Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin). | Q30576902 | ||
| 2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2 | Q33578562 | ||
| Dynamics of the STAT3 transcription factor: nuclear import dependent on Ran and importin-β1. | Q33916478 | ||
| mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells | Q34097241 | ||
| c-Cbl-mediated degradation of TRAIL receptors is responsible for the development of the early phase of TRAIL resistance. | Q34277650 | ||
| Utilization of the cellular stress response to sensitize cancer cells to TRAIL-mediated apoptosis | Q34286028 | ||
| Translational repression of MCL-1 couples stress-induced eIF2 alpha phosphorylation to mitochondrial apoptosis initiation | Q34635166 | ||
| Carnosic acid sensitized TRAIL-mediated apoptosis through down-regulation of c-FLIP and Bcl-2 expression at the post translational levels and CHOP-dependent up-regulation of DR5, Bim, and PUMA expression in human carcinoma caki cells | Q35176367 | ||
| Autophagosomal membrane serves as platform for intracellular death-inducing signaling complex (iDISC)-mediated caspase-8 activation and apoptosis | Q35874532 | ||
| Examination of a second node of translational control in the unfolded protein response | Q37168900 | ||
| Accumulation of autophagosomes in breast cancer cells induces TRAIL resistance through downregulation of surface expression of death receptors 4 and 5. | Q37299291 | ||
| p62/sequestosome-1 up-regulation promotes ABT-263-induced caspase-8 aggregation/activation on the autophagosome | Q37333720 | ||
| Translational control of eukaryotic gene expression | Q37551949 | ||
| Inhibition of eIF2α dephosphorylation enhances TRAIL-induced apoptosis in hepatoma cells | Q37620650 | ||
| Review: on TRAIL for malignant glioma therapy? | Q37681647 | ||
| TRAIL receptor gene editing unveils TRAIL-R1 as a master player of apoptosis induced by TRAIL and ER stress | Q37706093 | ||
| Proapoptotic DR4 and DR5 signaling in cancer cells: toward clinical translation | Q37784920 | ||
| Integrating stress signals at the endoplasmic reticulum: The BCL-2 protein family rheostat. | Q37814626 | ||
| Translating TRAIL-receptor targeting agents to the clinic. | Q38005273 | ||
| Repression of Mcl-1 and disruption of the Mcl-1/Bak interaction in myeloma cells couple ER stress to mitochondrial apoptosis | Q38738359 | ||
| Glucose Deprivation Induces ATF4-Mediated Apoptosis through TRAIL Death Receptors | Q38938720 | ||
| Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP. | Q39006307 | ||
| Monensin, a polyether ionophore antibiotic, overcomes TRAIL resistance in glioma cells via endoplasmic reticulum stress, DR5 upregulation and c-FLIP downregulation | Q39161204 | ||
| ZFX regulates glioma cell proliferation and survival in vitro and in vivo | Q39209883 | ||
| Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition | Q39435523 | ||
| ER stress sensitizes cells to TRAIL through down-regulation of FLIP and Mcl-1 and PERK-dependent up-regulation of TRAIL-R2. | Q39445601 | ||
| Importin β1 protein-mediated nuclear localization of death receptor 5 (DR5) limits DR5/tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced cell death of human tumor cells | Q39454078 | ||
| Autophagic degradation of active caspase-8: a crosstalk mechanism between autophagy and apoptosis | Q39665408 | ||
| The JNK pathway modulates expression and phosphorylation of 4E-BP1 in MIN6 pancreatic beta-cells under oxidative stress conditions. | Q39686886 | ||
| A single nucleotide polymorphism determines protein isoform production of the human c-FLIP protein | Q39851972 | ||
| Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation | Q39975655 | ||
| ATF4-mediated induction of 4E-BP1 contributes to pancreatic beta cell survival under endoplasmic reticulum stress | Q40006517 | ||
| DR5 receptor mediates anoikis in human colorectal carcinoma cell lines. | Q40017281 | ||
| Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs. | Q40287620 | ||
| Afatinib down-regulates MCL-1 expression through the PERK-eIF2α-ATF4 axis and leads to apoptosis in head and neck squamous cell carcinoma | Q40970957 | ||
| Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo | Q41483641 | ||
| The ER stress inducer DMC enhances TRAIL-induced apoptosis in glioblastoma. | Q42968961 | ||
| KPNB1, XPO7 and IPO8 mediate the translocation ofNF-κB/p65 into the nucleus | Q45049084 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 118 | |
| P577 | publication date | 2019-02-11 | |
| P1433 | published in | Cell Death and Disease | Q2197222 |
| P1476 | title | Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells | |
| P478 | volume | 10 |
| Q101166773 | KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway |
| Q64253207 | Natural Product Mediated Regulation of Death Receptors and Intracellular Machinery: Fresh from the Pipeline about TRAIL-Mediated Signaling and Natural TRAIL Sensitizers |
Search more.